首页 > 专栏 > The Lancet Diabetes & Endocrinology The Lancet Diabetes & Endocrinology 共 29 条资讯 [Articles] Whole-population trends in obesity across dimensions of inequality in England, 2019–25: a retrospective, longitudinal cohort study of 54 million adults 2026-06-28 08:37:47 [Comment] An important new data source for obesity trends in England 2026-06-28 08:37:47 [Personal View] Intermittent fasting to treat diabetes: time to update clinical practice guidelines 2026-06-28 08:37:47 [In Focus] ADA Scientific Sessions 2026: a line crossed 2026-06-28 08:37:47 [Correspondence] Weight management in China: integrating mental health into routine obesity care 2026-06-28 08:37:47 [Comment] Insulin and health systems in global low-resource settings 2026-06-28 08:37:47 [Articles] Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial 2026-06-28 08:37:47 [Articles] Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study 2026-06-28 08:37:47 [Review] Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement 2026-06-28 08:37:47 [Viewpoint] Goal-directed osteoporosis treatment: are bone mineral density targets valid? 2026-06-28 08:37:47 [Editorial] Energy drink ban: putting children's health first 2026-06-28 08:37:47 [Editorial] Soaring GLP-1 receptor agonist use 2026-06-28 08:37:47 [Correspondence] Do weight loss and weight cycling present a clinically meaningful risk in older patients? 2026-06-28 08:37:47 [Corrections] Correction to Lancet Diabetes Endocrinol 2025; 13: 935–48 2026-06-28 08:37:47 [Correspondence] Implications of microplastics as emerging endocrine disruptors 2026-06-28 08:37:47 [Comment] What REDEFINE 5 signals for obesity trials in Asia and beyond 2026-06-28 08:37:47 [Articles] Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, ph 2026-06-28 08:37:47 [Comment] A conceptual framework for modernising and right-sizing global diabetes care 2026-06-28 08:37:47 [Comment] Freedom through technology: transforming management of type 2 diabetes 2026-06-28 08:37:47 [Articles] Continuous glucose monitoring versus self-monitoring of blood glucose in individuals with type 2 diabetes: a randomised, multicentre, open-label, superiority trial 2026-06-28 08:37:47 12下一页 » 相关分类 The Lancet Diabetes & Endocrinology The Lancet #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi 38号车评中心